Assembly biosciences presents new data at aasld the liver meeting® highlighting breadth of virology portfolio and potential of next-generation core inhibitors in hbv

Data demonstrating nanomolar potency of core inhibitor abi-4334 to disrupt the hepatitis b virus (hbv) life cycle at multiple points supports advancement into clinical studies
ASMB Ratings Summary
ASMB Quant Ranking